Markets:

Overview

News

Currencies

International

Treasuries

Pfizer (NY:PFE)

26.03 +0.33 (+1.28%)

Official Closing Price Updated: 7:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

'It's Getting Ugly,' Analyst Says As Pfizer Escalates Its Gloves-Off Fight For Metsera ↗

November 06, 2025

Metsera stock surged Thursday on reports Pfizer has matched Novo Nordisk's $10 billion bid to buy the obesity-focused biotech.

Via Investor's Business Daily

Market Momentum Stalls: Valuations Under Scrutiny as Bullish Run Faces Headwinds

November 06, 2025

As November 2025 unfolds, the global stock markets find themselves at a critical juncture, struggling to reclaim the robust bullish momentum that characterized much of the preceding years. A palpable...

Via MarketMinute

Viatris’s (NASDAQ:VTRS) Q3 Sales Top Estimates

November 06, 2025

Medication company Viatris (NASDAQ:VTRS) beat Wall Street’s revenue expectations in Q3 CY2025, but sales were flat year on year at $3.76 billion. The company’s full-year revenue guidance of $14.1...

Via StockStory

Eli Lilly And Novo Nordisk Ignite Bullish Retail Frenzy Ahead Of TrumpRx Deals To Slash Prices For Weight-Loss Drugs ↗

November 04, 2025

Via Stocktwits

Why Pfizer's 7%-Yielding Dividend Just Became Safer -- and More Tempting ↗

November 06, 2025

Pfizer just gave income investors four reasons to like its juicy dividend even more.

Via The Motley Fool

Topics Earnings Intellectual Property

2 Dirt Cheap Stocks to Buy With $1,000 Right Now ↗

November 06, 2025

With big yields, these turnaround stocks look like they are attractively priced for those who can handle some uncertainty.

Via The Motley Fool

Novo Nordisk Snaps 11-Day Losing Streak After Court Rejects Pfizer’s Challenge To $10B Metsera Deal ↗

November 05, 2025

Delaware Chancery Judge Morgan Zurn ruled that Pfizer’s objections did not justify delaying Novo’s $10 billion acquisition of obesity-drug startup Metsera.

Via Stocktwits

Topics Law Enforcement

US Economic Resilience Fuels Dollar's Ascent Amidst Global Shifts

November 05, 2025

The United States economy is currently riding a wave of positive momentum, with a series of robust economic indicators signaling underlying strength and resilience. This optimistic outlook has, in...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Pfizer Responds to Delaware Chancery Court Ruling

November 05, 2025

From Pfizer Inc.

Via Business Wire

Navigating the Tempest: Market Consolidation Amidst Post-Slide Uncertainty

November 05, 2025

The financial markets, still reeling from a tumultuous period marked by significant downturns, are now grappling with an uneasy attempt at consolidation. As of November 5, 2025, investors are...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Obesity Drugmakers Face Shifting Tides: Novo Nordisk Plunges While Eli Lilly Soars

November 05, 2025

The burgeoning market for obesity and diabetes treatments, particularly GLP-1 receptor agonists, is witnessing a dramatic divergence in fortunes among its leading players. As of November 5, 2025, Novo...

Via MarketMinute

Topics Economy

US Government Shutdown Casts a Shadow: Data Blackout and Market Jitters as Longest Shutdown Unfolds

November 05, 2025

The United States finds itself in an unprecedented economic fog as a prolonged government shutdown, now stretching well into its second month, has brought the flow of critical official data to a...

Via MarketMinute

Topics Economy

These S&P500 stocks are the most active in today's session ↗

November 05, 2025

Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Wednesday. Discover the stocks that are generating the highest...

Via Chartmill

10 Health Care Stocks Whale Activity In Today's Session ↗

November 05, 2025

Via Benzinga

AI Achieves Atomic Precision in Antibody Design: A New Era for Drug Discovery Dawns

November 05, 2025

Seattle, WA – November 5, 2025 – In a monumental leap for biotechnology and artificial intelligence, Nobel Laureate David Baker’s lab at the University of Washington’s Institute for Protein Design...

Via TokenRing AI

Topics Artificial Intelligence Intellectual Property

Here's Why Shares in Viking Therapeutics Shot Higher in October ↗

November 05, 2025

Three factors took Viking's shares higher in the month.

Via The Motley Fool

3 Magnificent Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 8.5% -- to Buy With Confidence in November ↗

November 05, 2025

These supercharged income stocks have the necessary catalysts to pad the pocketbooks of patient investors.

Via The Motley Fool

U.S. Government Shutdown Plunges Nation into Uncharted Economic Waters: Longest in History Deepens Market Uncertainty

November 05, 2025

Washington D.C., November 5, 2025 – The United States is grappling with an unprecedented fiscal crisis, as an ongoing government shutdown, now in its 36th day, has officially become the longest in the...

Via MarketMinute

Topics Bonds Economy Government

Can Novo Nordisk’s ‘Attractive’ Fundamentals Outweigh Slowing Wegovy Sales And A $149 Price Cap? ↗

November 05, 2025

Novo Nordisk cut its 2025 profit and sales forecasts as slower GLP-1 growth and pricing pressure hit margins.

Via Stocktwits

Topics Lawsuit

PFE Q3 Deep Dive: Pipeline, Cost Controls, and Business Development Shape Outlook

November 05, 2025

Global pharmaceutical company Pfizer (NYSE:PFE) met Wall Streets revenue expectations in Q3 CY2025, but sales fell by 5.9% year on year to $16.65 billion. On the other hand, the company’s full-year...

Via StockStory

U.S. PMI Data Looms: A Pivotal Moment for the Dollar and Global Markets

November 04, 2025

The financial world is holding its breath as the release of the upcoming U.S. Purchasing Managers' Index (PMI) data draws near. This crucial economic indicator is not merely a snapshot of business...

Via MarketMinute

Topics Bonds Economy Supply Chain

AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential

November 04, 2025

The burgeoning fields of cell and gene therapy (CGT) are on the cusp of a profound revolution, driven by the relentless advancements in artificial intelligence. This transformative impact was a central...

Via TokenRing AI

Topics Artificial Intelligence

Precious Metals Under Pressure: Dollar Rallies, Stocks Retreat, and Rate Outlook Weighs Heavily

November 04, 2025

As of November 4, 2025, the global financial markets are witnessing a significant shift, with a rallying US dollar and a retreating stock market exerting considerable downward pressure on gold and...

Via MarketMinute

Topics Economy Stocks Supply Chain

Novo, Pfizer Are Battling To Buy The Future Of Weight-Loss — But Viking Already Owns It ↗

November 04, 2025

Viking Global's $45 million investment in Metsera, a biotech company is caught in a bidding war between Pfizer and Novo Nordisk.

Via Benzinga

Pfizer, Novo Nordisk Intensify Fight For Metsera As Buyout Offers Continue To Climb ↗

November 04, 2025

Novo Nordisk boosts its Metsera bid to $62.20 per share, valuing the company at $10 billion and outbidding Pfizer in the escalating takeover fight.

Via Benzinga

Curious about the most active S&P500 stocks in today's session? ↗

November 04, 2025

Stay informed about the most active stocks in the S&P500 index on Tuesday's session. Discover the stocks that are generating the highest trading volume and driving market activity.

Via Chartmill

Most active stocks in Tuesday's session ↗

November 04, 2025

Let's have a look at what is happening on the US markets on Tuesday. Below you can find the most active stocks in today's session.

Via Chartmill

Pfizer Q3 Revenue Trends Remain Uneven, Cost Cuts Drive Earnings ↗

November 04, 2025

Pfizer revenue trends remained uneven in the third quarter, the company exhibited "continued cost discipline," according to Goldman Sachs.

Via Benzinga

These S&P500 stocks have an unusual volume in today's session ↗

November 04, 2025

In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Tuesday's session.

Via Chartmill

Palantir Weighs On Wall Street, Bitcoin Slumps 5%: What's Moving Markets Tuesday? ↗

November 04, 2025

Risk appetite cooled on Tuesday as investors interpreted the latest batch of corporate earnings as solid but not spectacular, offering a convenient excuse to take profits after strong year-to-date...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.